External Quality Control of ER, PR, and HER2 Immunohistochemistry and Continued Need for Optimization
13 Dec 2012

Breast pathology routinely employs immunohistochemistry for the classification and subsequent selection of patients for specific therapies. However, correct interpretation, is dependent on the quality of the staining produced, which can vary enormously between laboratories, and in some instanced show day-to-day variation within the same laboratory. Therefore, it is vital that laboratories not only use standardized staining procedures for ER,PR and HER2 immunohistochemistry but also optimize protocols as required.

Leica Microsystems



Show    per page
1 of 10 Page     1 2 3  ... Next 
Avoiding Bottlenecks When Validating Your Laboratory Instrument and Information Systems20 Aug 2014Read
A New Concept in Metabolic Studies: How Personalized 'Sportomics' Bridges Bench and Clinical Science24 Jul 2014Read
Process development and optimisation using ambr250™ for mammalian and microbial processes2 Jul 2014Read
Why does ice cream taste smooth or gritty? It depends on the rheology!30 Jun 2014Read
Masterclass 4: Configuring optical parameters for laser diffraction particle size analysis30 Jun 2014Read
The Science of Beauty - Characterizing Hyaluronic Acid - the molecule behind anti-aging creams30 Jun 2014Read
Polymer solution characterization part 3: Branching out! Intrinsically useful views on polymer structure30 Jun 2014Read
Optical Properties of Organic Compounds: obtaining the refractive index and absorption values for use in laser diffraction particle size analysis30 Jun 2014Read
Configuring optical parameters for laser diffraction particle size analysis19 Jun 2014Read
Click Chemistry Reagents Labeled with DBCO Groups Allow for Copper-Free Biomolecule Labeling Reactions18 Jun 2014Read